Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle
AUTOR(ES)
Sanoudou, Despina
FONTE
The National Academy of Sciences
RESUMO
The nemaline myopathies (NMs) are a clinically and genetically heterogeneous group of disorders characterized by nemaline rods and skeletal muscle weakness. Mutations in five sarcomeric thin filament genes have been identified. However, the molecular consequences of these mutations are unknown. Using Affymetrix oligonucleotide microarrays, we have analyzed the expression patterns of >21,000 genes and expressed sequence tags in skeletal muscles of 12 NM patients and 21 controls. Multiple complementary approaches were used for data analysis, including geometric fold analysis, two-tailed unequal variance t test, hierarchical clustering, relevance network, and nearest-neighbor analysis. We report the identification of high satellite cell populations in NM and the significant down-regulation of transcripts for key enzymes of glucose and glycogen metabolism as well as a possible regulator of fatty acid metabolism, UCP3. Interestingly, transcript level changes of multiple genes suggest possible changes in Ca2+ homeostasis. The increased expression of multiple structural proteins was consistent with increased fibrosis. This comprehensive study of downstream molecular consequences of NM gene mutations provides insights in the cellular events leading to the NM phenotype.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=153613Documentos Relacionados
- Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy.
- Nemaline Myopathy Caused by Mutations in the Muscle α-Skeletal-Actin Gene
- Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency
- A nemaline myopathy mutation in α-tropomyosin causes defective regulation of striated muscle force production
- Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy